Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03510-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sofna Banjarnahor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany. Hauptthemen laut MEDLINE: Arginine, Homoarginine, Amino Acid Transport Systems, Basic. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Friedrich-Alexander-Universität Erlangen-Nürnberg.
Abstract (Originalsprache)
L-arginine and its (patho-)physiologically active derivatives, L-homoarginine and asymmetric dimethylarginine (ADMA), show significant differences in their renal clearance. The underlying molecular mechanisms remain to be elucidated, but selective tubular transport protein-mediated mechanisms likely play a role. In the present study, we investigate the human heteromeric transporter b 0,+ AT-rBAT (encoded by the SLC7A9 and SLC3A1 genes) as a potential candidate because it is localized in the luminal membrane of human proximal tubule cells and capable of mediating the cellular uptake of amino acids, including L-arginine. Double-transfected Madin-Darby canine kidney (MDCK) cells stably expressing human b 0,+ AT-rBAT exhibited significant uptake of L-arginine and L-homoarginine, with apparent K m values of 512.6 and 197.0 μM, respectively. On the contrary, ADMA uptake was not saturated up to 4000 μM, with a transport rate > 5 nmol × mg protein −1 × min −1 . With an IC 50 value of 115.8 μM, L-arginine inhibited L-homoarginine uptake. Conversely, L-arginine only exhibited a partial inhibitory effect on ADMA uptake. Taken together, our data indicate that b 0,+ AT-rBAT may contribute to the differential renal handling of L-arginine, L-homoarginine, and ADMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
- Research Centre for Pharmaceutical Ingredient and Traditional Medicine, Cibinong Science Center, National Research and Innovation Agency (BRIN), 16911, Cibinong, Jawa Barat, Indonesia.
- Institute of Pharmacy, Universität Regensburg, 93040, Regensburg, Germany.
- FAU NeW Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
- Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany. Renke.Maas@fau.de.
- FAU NeW Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany. Renke.Maas@fau.de.
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Friedrich-Alexander-Universität Erlangen-Nürnberg
Zitieren
APA
Banjarnahor, S., Scherpinski, L. A., Keller, M., König, J., & Maas, R. (2025). Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1). Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03510-z
Vancouver
Banjarnahor S, Scherpinski LA, Keller M, König J, Maas R. Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1). Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03510-z
BibTeX
@article{Banjarnahor2025,
author = {Banjarnahor, Sofna and Scherpinski, Lorenz A and Keller, Max and König, Jörg and Maas, Renke},
title = {Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1)},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03510-z}
}
EUVIMED